Millions of Americans living with heart failure are not receiving medications that have been proven for decades to ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

Research shows Type 2 diabetes isn't just a risk factor; it directly damages heart structure and energy systems. This “silent killer” reshapes the heart, accelerating failure at a molecular level.

We are fighting for transparency, accountable science, and for the rights of the common people to receive informed consent.

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the ...

Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...

AI and digital health devices should not be viewed as replacements for health care professionals, but as tools that can be ...

Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.

For years, semaglutide was framed as a powerful tool for diabetes and weight loss. Now cardiologists are confronting a more ...

From AI-powered drug discovery to regenerative therapies and next-generation neurology tools, Mayo Clinic researchers made significant strides in 2025 toward predicting, preventing and treating some o ...

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...